Named as a key player in 33 of our reports, across 33 regions and countries.
[1] ClinicalTrials.gov, Studies led by University of Pennsylvania or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Our reports that name University of Pennsylvania as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as University of Pennsylvania (number of shared markets).
Azusa Pacific University1 shared market
BD (Becton, Dickinson)1 shared market
bioMérieux SA1 shared market
Danaher Corporation1 shared market
Duke University1 shared market
Johns Hopkins University1 shared market
Roche Diagnostics1 shared market
Siemens Healthineers1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
351 active studies led by University of Pennsylvania, of 1,668 in all
Source: ClinicalTrials.gov, Studies with University of Pennsylvania (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies University of Pennsylvania leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with University of Pennsylvania or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets University of Pennsylvania is in.
Stories on the topics University of Pennsylvania works in.
The world has 29.8 million nurses, but still lacks 5.8 million. Training and keeping nurses is a global…
Read
The world spent about US$9.8 trillion on health in 2021. Hospitals face staff shortages, patient safety…
ReadSearch all reports for University of Pennsylvania All companies